Lista articolelor în limba engleza
Afisarea articolelor: 1-4(4)
2022
| 1. | Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB-506 from Phase 1 studies in healthy subjects and those with hepatitis B . Hepatology Communications. 2022, nr. , 3472-3457. ISSN 2471-254X. (Cat. ) |
| 2. | HBsAg isoform dynamics during NAP-based therapy of HBeAg-negative chronic HBV and HBV/HDV infection . Hepatology Communications. 2022, nr. , 1880-1870. ISSN 2471-254X. (Cat. ) |
2021
| 3. | Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP-Based Therapy . Hepatology Communications. 2021, nr. , 1887-1873. ISSN 2471-254X. (Cat. ) |
| 4. | Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139-Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection . Hepatology Communications. 2021, nr. , 202-189. ISSN 2471-254X. (Cat. ) |
    |
1-4 of 4
